Sunzen Group Bhd

Sunzen Group Bhd EBITDA per Share

The EBITDA per Share of Sunzen Group Bhd (SUNZEN.KL) as of Oct 29, 2026 is 0.01 MYR. In the previous year, EBITDA per Share was 0.02 MYR — a change of -67.05% (lower).

EBITDA per Share

0.01MYR

YoY

-67.05%

Last updated:

EBITDA per Share of Sunzen Group Bhd is 2025 0.01 MYR. EBITDA per Share of Sunzen Group Bhd was 2024 0.02 MYR. It decreases by -67.05% lower compared to the previous year.

The Sunzen Group Bhd EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
-0.01 MYR
Jan 1, 2019
-0.04 MYR
Jan 1, 2020
-0.02 MYR
Jan 1, 2021
0.01 MYR
Jan 1, 2022
0.01 MYR
Jan 1, 2023
0.01 MYR
Jan 1, 2024
0.02 MYR
Jan 1, 2025
0.01 MYR
The Sunzen Group Bhd EBITDA per Share history
YEAREBITDA per ShareYoY
0.01MYR-67.05%
0.02MYR+203.71%
0.01MYR-38.64%
0.01MYR+95.06%
0.01MYR-124.27%
-0.02MYR-36.81%
-0.04MYR+270.82%
-0.01MYR-267.67%
0.01MYR-1,705.20%
-0.00MYR+184.76%
-0.00MYR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sunzen Group Bhd Stock analysis

What does Sunzen Group Bhd do? Sunzen Biotech Bhd. generates revenue through its four business segments: manufacturing and trading of animal health products, trading and processing of crude palm oil and related products, traditional Chinese medicines and herbal health foods and beverages, and loan financing. Its products, including bird's nest, The Joy of Life collagen drink, Pu Yao Jing tonic, essence of chicken, essence of fish, Pi Pa Gao cough syrup, and Bai Foong Wan, are sold via retail concept stores in Malaysia and the Ecolite online shop. The company's subsidiaries, such as Sunzen Corporation Sdn. Bhd. and Sunzen Lifesciences Sdn. Bhd., support these operations. Customers include consumers purchasing health and wellness products through physical stores and online platforms. The firm's animal health products segment focuses on feed supplements for animals, while the crude palm oil segment handles trading and processing of palm oil derivatives. Traditional Chinese medicine products like Pi Pa Gao cough syrup and Bai Foong Wan target health-conscious consumers. Loan financing through Finsource Credit (M) Sdn. Bhd. provides financial services to customers seeking credit solutions. Sunzen International Sdn. Bhd. likely manages international distribution of products, and Sunzen Lifesciences Sdn. Bhd. supports biotechnology research and development. The company's product portfolio spans health drinks, herbal remedies, and financial services, with sales driven by retail stores and online channels in Malaysia. Sunzen Group Bhd is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sunzen Group Bhd stock

EBITDA per Share of Sunzen Group Bhd is 0.01 MYR in 2025.

EBITDA per Share of Sunzen Group Bhd changed from 0.02 MYR to 0.01 MYR, representing a -67.05% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Sunzen Group Bhd since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Sunzen Group Bhd

All Key Metrics — Sunzen Group Bhd